Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the Unfinished Agenda of Staging Reproductive Aging

Overview

Journal Menopause

Specialty Gynecology & Obstetrics

Date 2012 Feb 21

PMID 22343510

Citations 242

Authors

Sioban D Harlow

Margery Gass

Janet E Hall

Roger Lobo

Pauline Maki

Robert W Rebar

Sherry Sherman

Patrick M Sluss

Tobie J de Villiers

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this article is to summarize the recommended updates to the 2001 Stages of Reproductive Aging Workshop (STRAW) criteria. The 2011 STRAW + 10 reviewed advances in understanding of the critical changes in hypothalamic-pituitary-ovarian function that occur before and after the final menstrual period.

Methods: Scientists from five countries and multiple disciplines evaluated data from cohort studies of midlife women and in the context of chronic illness and endocrine disorders on change in menstrual, endocrine, and ovarian markers of reproductive aging including antimüllerian hormone, inhibin-B, follicle-stimulating hormone, and antral follicle count. Modifications were adopted by consensus.

Results: STRAW + 10 simplified bleeding criteria for the early and late menopausal transition, recommended modifications to criteria for the late reproductive stage (Stage -3) and the early postmenopause stage (Stage +1), provided information on the duration of the late transition (Stage -1) and early postmenopause (Stage +1), and recommended application regardless of women's age, ethnicity, body size, or lifestyle characteristics.

Conclusions: STRAW + 10 provides a more comprehensive basis for assessing reproductive aging in research and clinical contexts. Application of the STRAW + 10 staging system should improve comparability of studies of midlife women and facilitate clinical decision making. Nonetheless, important knowledge gaps persist, and seven research priorities are identified.

Citing Articles

The acute impact of resistance exercise training on cardiovascular parameters in trained and untrained adults with high blood pressure.

Banks N, Rogers E, Stanhewicz A, Whitaker K, Jenkins N Eur J Appl Physiol. 2025; .

PMID: 40088269 DOI: 10.1007/s00421-025-05754-w.

Comparative performance of PROMIS Sleep Disturbance computerized adaptive testing algorithms and static short form in postmenopausal women.

Trigg A, Haberland C, Shalhoub H, Gerlinger C, Seitz C J Patient Rep Outcomes. 2025; 9(1):18.

PMID: 39961968 PMC: 11832987. DOI: 10.1186/s41687-025-00849-6.

Strength training for osteoporosis prevention during early menopause (STOP-EM): a pilot study protocol for a single centre randomised waitlisted control trial in Canada.

Alexander C, Kaluta L, Whitman P, Billington E, Burt L, Gabel L BMJ Open. 2025; 15(2):e093711.

PMID: 39909519 PMC: 11800298. DOI: 10.1136/bmjopen-2024-093711.

Hormone replacement therapy, menopausal age and lifestyle variables are associated with better cognitive performance at follow-up but not cognition over time in older-adult women irrespective of APOE4 carrier status and co-morbidities.

Watermeyer T, Gregory S, Leetham E, Udeh-Momoh C, Muniz-Terrera G Front Dement. 2025; 3:1496051.

PMID: 39897117 PMC: 11782126. DOI: 10.3389/frdem.2024.1496051.

Ovarian function in adolescents and young adults undergoing cancer treatment: biochemical and ultrasound marker analysis.

Signorino C, Bencini E, Tondo A, Scalini P, Tamburini A, Casini T Endocr Connect. 2025; 14(4).

PMID: 39887687 PMC: 11896650. DOI: 10.1530/EC-24-0511.

References

Soules M, Sherman S, Parrott E, Rebar R, Santoro N, Utian W . Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 2001; 76(5):874-8. DOI: 10.1016/s0015-0282(01)02909-0. View

La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio A . Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2009; 16(2):113-30. DOI: 10.1093/humupd/dmp036. View

Sowers M, Eyvazzadeh A, McConnell D, Yosef M, Jannausch M, Zhang D . Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008; 93(9):3478-83. PMC: 2567855. DOI: 10.1210/jc.2008-0567. View

Soules M, Sherman S, Parrott E, Rebar R, Santoro N, Utian W . Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001. Menopause. 2010; 8(6):402-7. DOI: 10.1097/00042192-200111000-00004. View

Ferrell R, Sowers M . Longitudinal, epidemiologic studies of female reproductive aging. Ann N Y Acad Sci. 2010; 1204:188-97. DOI: 10.1111/j.1749-6632.2010.05525.x. View

Hansen K, Morris J, Thyer A, Soules M . Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil Steril. 2003; 80(3):577-83. DOI: 10.1016/s0015-0282(03)00741-6. View

Santoro N, Arnsten J, Buono D, Howard A, Schoenbaum E . Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women. J Womens Health (Larchmt). 2005; 14(10):898-905. DOI: 10.1089/jwh.2005.14.898. View

Woods N, Mitchell E . Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep. 2010; 33(4):539-49. PMC: 2849794. DOI: 10.1093/sleep/33.4.539. View

Maki P, Freeman E, Greendale G, Henderson V, Newhouse P, Schmidt P . Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause. 2010; 17(4):815-22. PMC: 2901893. DOI: 10.1097/gme.0b013e3181d763d2. View

10.

Randolph Jr J, Zheng H, Sowers M, Crandall C, Crawford S, Gold E . Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab. 2010; 96(3):746-54. PMC: 3047231. DOI: 10.1210/jc.2010-1746. View

11.

Sievert L, Begum K, Sharmeen T, Chowdhury O, Muttukrishna S, Bentley G . Patterns of occurrence and concordance between subjective and objective hot flashes among Muslim and Hindu women in Sylhet, Bangladesh. Am J Hum Biol. 2008; 20(5):598-604. DOI: 10.1002/ajhb.20785. View

12.

Stiles M, Redmer J, Paddock E, Schrager S . Gynecologic issues in geriatric women. J Womens Health (Larchmt). 2011; 21(1):4-9. DOI: 10.1089/jwh.2011.2803. View

13.

Flegal K, Carroll M, Ogden C, Curtin L . Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303(3):235-41. DOI: 10.1001/jama.2009.2014. View

14.

van Rooij I, Broekmans F, Scheffer G, Looman C, Habbema J, de Jong F . Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005; 83(4):979-87. DOI: 10.1016/j.fertnstert.2004.11.029. View

15.

Sammel M, Freeman E, Liu Z, Lin H, Guo W . Factors that influence entry into stages of the menopausal transition. Menopause. 2009; 16(6):1218-27. PMC: 2783664. DOI: 10.1097/gme.0b013e3181a8f62b. View

16.

Burger H, Hale G, Robertson D, Dennerstein L . A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update. 2007; 13(6):559-65. DOI: 10.1093/humupd/dmm020. View

17.

Mitchell E, Woods N, Mariella A . Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause. 2000; 7(5):334-49. DOI: 10.1097/00042192-200007050-00008. View

18.

Huddleston H, Cedars M, Sohn S, Giudice L, Fujimoto V . Racial and ethnic disparities in reproductive endocrinology and infertility. Am J Obstet Gynecol. 2010; 202(5):413-9. DOI: 10.1016/j.ajog.2009.12.020. View

19.

van Disseldorp J, Faddy M, Themmen A, de Jong F, Peeters P, van der Schouw Y . Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab. 2008; 93(6):2129-34. DOI: 10.1210/jc.2007-2093. View

20.

Bidet M, Bachelot A, Bissauge E, Golmard J, Gricourt S, Dulon J . Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab. 2011; 96(12):3864-72. DOI: 10.1210/jc.2011-1038. View